By Matt Jones

NEW YORK (GenomeWeb News) – Any new policies developed to address concerns about what happens to blood spots collected from newborns should focus on allowing the parents to choose what happens to these samples, which are valuable to researchers long after they are used for newborn screening, according to University of Michigan Health System pediatrician Beth Tarini.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.